pindolol has been researched along with adenosine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Markstein, R; Wagner, H | 1 |
| Lee, JT; Newman, WH; Webb, JG | 1 |
| Malta, E; Molenaar, P | 1 |
| Hattori, Y; Kanno, M; Nakao, Y; Sakuma, I | 1 |
| Freissmuth, M; Hausleithner, V; Schütz, W; Tuisl, E | 1 |
| Kraupp, O | 1 |
| Endoh, M; Yamashita, S | 1 |
| Alexander, SP; Hernández, F; Kendall, DA; Neil, KE | 1 |
2 review(s) available for pindolol and adenosine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Phrmacodynamic principles underlying the specific therapy of coronary vascular disease].
Topics: Adenosine; Adrenergic beta-Antagonists; Chemical Phenomena; Chemistry; Coronary Disease; Coronary Vessels; Hemodynamics; Humans; Myocardium; Oxygen; Oxygen Consumption; Pindolol; Propranolol; Vasodilator Agents | 1973 |
12 other study(ies) available for pindolol and adenosine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Effect of dihydroergotoxine on cyclic-AMP-generating systems in rat cerebral cortex slices.
Topics: Adenosine; Animals; Cerebral Cortex; Cyclic AMP; Dihydroergotoxine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Isoproterenol; Male; Norepinephrine; Phentolamine; Pindolol; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1978 |
Persistent desensitization of the heart to the inotropic action of isoproterenol by adenosine.
Topics: Adenosine; Adenylyl Cyclases; Animals; Coronary Circulation; Guinea Pigs; Heart; In Vitro Techniques; Iodocyanopindolol; Isoproterenol; Membranes; Myocardial Contraction; Myocardium; Norepinephrine; Ouabain; Perfusion; Pindolol; Radioimmunoassay; Receptors, Purinergic | 1989 |
Analysis of agonist dissociation constants as assessed by functional antagonism in guinea pig left atria.
Topics: Adenosine; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzofurans; Carbachol; Catechols; Gallopamil; Guinea Pigs; Heart; In Vitro Techniques; Iodine Radioisotopes; Isoproterenol; Kinetics; Male; Myocardial Contraction; Nifedipine; Pindolol; Propanolamines | 1986 |
Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
Topics: Adenosine; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carbachol; Cyclic AMP; Dose-Response Relationship, Drug; Female; Guanylyl Imidodiphosphate; Guinea Pigs; Heart; Heart Rate; Iodocyanopindolol; Isoproterenol; Male; Myocardial Contraction; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Xamoterol | 1987 |
Cardiac sarcolemmal purity is essential for the verification of adenylate cyclase inhibition via A1-adenosine receptors.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Animals; Cell Membrane; Guinea Pigs; Iodocyanopindolol; Myocardium; Ouabain; Pindolol; Receptors, Cell Surface; Receptors, Purinergic; Sarcolemma | 1986 |
Adenosine antagonizes the positive inotropic action mediated via beta-, but not alpha-adrenoceptors in the rabbit papillary muscle.
Topics: Adenosine; Animals; Carbachol; Drug Interactions; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Papillary Muscles; Phenylephrine; Pindolol; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1980 |
Heterogeneity of beta-adrenoceptors in guinea-pig brain: radioligand binding and cyclic nucleotide generation.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Binding, Competitive; Cerebellum; Cyclic AMP; Cyclic GMP; Female; Guinea Pigs; Inositol Phosphates; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Male; Pindolol; Population; Propanolamines; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta; Signal Transduction; Vasodilator Agents | 1997 |